ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+20.89%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$261M
AUM Growth
+$261M
(+81%)
Cap. Flow
+$98.2M
Cap. Flow
% of AUM
37.67%
Top 10 Holdings %
Top 10 Hldgs %
68.46%
Holding
43
New
15
Increased
8
Reduced
6
Closed
9
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$26M |
| 2 |
CELG
Celgene Corp
CELG
|
$17.2M |
| 3 |
Amicus Therapeutics
FOLD
|
$15.1M |
| 4 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$15.1M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$9.41M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$7.17M |
| 2 |
MacroGenics
MGNX
|
$5.7M |
| 3 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$4.23M |
| 4 |
Arrowhead Research
ARWR
|
$3.88M |
| 5 |
Dynavax Technologies
DVAX
|
$3.36M |
Sector Composition
| 1 | Healthcare | 83.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amicus Therapeutics
FOLD
$2.34B
| $45.8M | 17.58% | 4,211,399 +1,387,214 | +49% | +$15.1M |
|
|
2
Iovance Biotherapeutics
IOVA
$807M
| $26M | 9.99% | +2,149,907 | New | +$26M |
|
|
SRNE
3
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $25.6M | 9.82% | 2,214,043 +1,303,943 | +143% | +$15.1M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $17.2M | 6.58% | +148,800 | New | +$17.2M |
|
|
PTX
5
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $14.9M | 5.72% | 1,395,167 +260,589 | +23% | +$2.79M |
|
|
BLCM
6
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $11M | 4.22% | 475,015 +255,015 | +116% | +$5.91M |
|
|
AGEN
7
Agenus
AGEN
$133M
| $10.5M | 4.03% | 2,047,971 -590,100 | -22% | -$3.03M |
|
8
Emergent Biosolutions
EBS
$443M
| $9.51M | 3.65% | 330,635 | – | – |
|
|
MRTX
9
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.41M | 3.61% | +320,867 | New | +$9.41M |
|
|
LJPC
10
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $8.45M | 3.24% | 461,499 +215,000 | +87% | +$3.93M |
|
|
TARO
11
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $7.59M | 2.91% | 53,800 -30,000 | -36% | -$4.23M |
|
|
CASC
12
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $7.32M | 2.81% | 4,491,636 +1,500,000 | +50% | +$2.44M |
|
|
RCPT
13
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $7.26M | 2.78% | 44,000 -43,500 | -50% | -$7.17M |
|
|
STML
14
DELISTED
Stemline Therapeutics, Inc.
STML
| $6.87M | 2.64% | +475,000 | New | +$6.87M |
|
|
TLGT
15
DELISTED
Teligent, Inc
TLGT
| $5.88M | 2.26% | 720,908 +258,566 | +56% | +$2.11M |
|
16
uniQure
QURE
$896M
| $5.51M | 2.11% | +226,456 | New | +$5.51M |
|
17
Tonix Pharmaceuticals
TNXP
$260M
| $4.77M | 1.83% | +755,300 | New | +$4.77M |
|
18
Vericel Corp
VCEL
$1.83B
| $3.92M | 1.5% | 1,058,820 | – | – |
|
|
AVDL
19
Avadel Pharmaceuticals
AVDL
$1.43B
| $3.88M | 1.49% | 215,705 +900 | +0.4% | +$16.2K |
|
20
Sangamo Therapeutics
SGMO
$157M
| $3.83M | 1.47% | +244,199 | New | +$3.83M |
|
|
TRIL
21
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.23M | 1.24% | +160,697 | New | +$3.23M |
|
|
CCXI
22
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.44M | 0.94% | +323,607 | New | +$2.44M |
|
23
TherapeuticsMD
TXMD
$12.8M
| $2.37M | 0.91% | +392,000 | New | +$2.37M |
|
24
Fortress Biotech
FBIO
$76.8M
| $2.31M | 0.89% | +600,000 | New | +$2.31M |
|
25
Cardiff Oncology
CRDF
$140M
| $2.21M | 0.85% | +323,728 | New | +$2.21M |
|